I'm late to the party. This performance-enhancing drug has been banned as a prohibited substance by WADA effective January 1, 2023.
Volelotor (trade name Oxbryta) is a first-in-class medication for the treatment of sickle cell disease (and resulting hemolytic anemia).
It was approved by the US...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.